Immune reconstitution inflammatory syndrome in a unique clinical scenario

Por Anubhav, G., Kamath, N. K.
Publicado em 2010

Calmodulin inhibitor trifluoperazine in combination with doxorubicin induces the selection of tumour cells with the multidrug resistant phenotype.

Por Kamath, N., Grabowski, D., Ford, J., Ganapathi, R.
Publicado em 1993

Clinical and Genetic Profile of Indian Children with Primary Hyperoxaluria

Por Pinapala, A., Garg, M., Kamath, N., Iyengar, A.
Publicado no Indian J Nephrol (2017)

Cyclosporine/ketoconazole reduces treatment costs for nephrotic syndrome

Por Iyengar, A., Kamath, N., Phadke, K. D., Bitzan, M.
Publicado em 2013

WR‐1065, an active metabolite of the cytoprotector amifostine, affects phosphorylation of topoisomerase IIα leading to changes in enzyme activity and cell cycle progression in CHO...

Por Murley, J. S., Constantinou, A., Kamath, N. S., Grdina, D. J.
Publicado no Cell Prolif (2003)

Urinary indices during relapse of childhood nephrotic syndrome

Por Iyengar, A. A., Kamath, N., Vasudevan, A., Phadke, K. D.
Publicado em 2011

Feasibility of screening for urinary abnormalities as a part of school health appraisal

Por Iyengar, A., Goud, B. R., Kamath, N., Phadke, K. D., Kasthuri, A.
Publicado em 2012